Larson Financial Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.21K Sell
222
-439
-66% -$12.4K ﹤0.01% 2667
2026
Q1
$18.9K Buy
661
+137
+26% +$4.67K ﹤0.01% 1879
2025
Q4
$20.7K Hold
524
﹤0.01% 1703
2025
Q3
$18.5K Buy
524
+169
+48% +$5.82K ﹤0.01% 1683
2025
Q2
$11.6K Sell
355
-53
-13% -$1.72K ﹤0.01% 1733
2025
Q1
$13.2K Sell
408
-104
-20% -$3.86K ﹤0.01% 1531
2024
Q4
$15.6K Buy
512
+157
+44% +$5.05K ﹤0.01% 1312
2024
Q3
$9.95K Buy
+355
New +$8.75K ﹤0.01% 1482
2024
Q2
Sell
-17,270
Closed -$525K 2432
2024
Q1
$525K Sell
17,270
-1,363
-7% -$45.7K 0.04% 239
2023
Q4
$665K Sell
18,633
-4,399
-19% -$164K 0.06% 186
2023
Q3
$1.01M Buy
23,032
+838
+4% +$40.9K 0.1% 155
2023
Q2
$1.1M Buy
22,194
+1,314
+6% +$60.6K 0.11% 153
2023
Q1
$865K Buy
20,880
+99
+0.5% +$4.11K 0.09% 164
2022
Q4
$922K Sell
20,781
-1,764
-8% -$73.7K 0.11% 154
2022
Q3
$882K Buy
22,545
+22,325
+10,148% +$1.02M 0.13% 137
2022
Q2
$9K Buy
+220
New +$10.4K ﹤0.01% 734

Other funds holding ATRC

Larson Financial Group's ATRC Position: Q2 2026 in Review

Larson Financial Group reduced its AtriCure (ATRC) stake by 66% in Q2 2026, selling an estimated $12.4K and leaving 222 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

Larson Financial Group first reported a position in ATRC in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.1M in Q2 2023. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Larson Financial Group held 222 shares of AtriCure worth $6.21K as of Q2 2026.
  • Larson Financial Group sold 439 AtriCure shares in Q2 2026, an estimated $12.4K.
  • AtriCure made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2667 holding.
  • Larson Financial Group first reported a position in AtriCure in Q2 2022 and has held it in 16 quarters since.
  • Larson Financial Group's AtriCure position peaked at $1.1M in Q2 2023.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.